Cite
Năstase F, Radaschin DS, Niculeț E, et al. Gadolinium-based contrast agents in neurofibromatosis type 1 (Review). Exp Ther Med. 2021;21(5):530doi: 10.3892/etm.2021.9962.
Năstase, F., Radaschin, D. S., Niculeț, E., Stefanescu, B. I., Nechita, A., Miruna, D., Baroiu, L., Manuela, A., & Tatu, A. L. (2021). Gadolinium-based contrast agents in neurofibromatosis type 1 (Review). Experimental and therapeutic medicine, 21(5), 530. https://doi.org/10.3892/etm.2021.9962
Năstase, Florentina, et al. "Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)." Experimental and therapeutic medicine vol. 21,5 (2021): 530. doi: https://doi.org/10.3892/etm.2021.9962
Năstase F, Radaschin DS, Niculeț E, Stefanescu BI, Nechita A, Miruna D, Baroiu L, Manuela A, Tatu AL. Gadolinium-based contrast agents in neurofibromatosis type 1 (Review). Exp Ther Med. 2021 May;21(5):530. doi: 10.3892/etm.2021.9962. Epub 2021 Mar 23. PMID: 33815603; PMCID: PMC8014979.
Copy
Download .nbib